| Health / Medical Topics |
Melan-A/MAGE-3.DP4 Peptide Vaccine
A cancer vaccine consisting of a peptide derived from the melanocyte differentiation antigen Melan-A (or MART-1) and the human leukocyte antigen HLA-DP4-restricted human melanoma antigen 3 (MAGE-3.DP4), with potential immunostimulating and antineoplastic activities. Upon administration, Melan-A/MAGE-3.DP4 peptide vaccine may stimulate the immune system to mount a cytotoxic T-cell (CTL) response against tumor cells expressing Melan-A and MAGE-3, resulting in tumor cell lysis. The tumor associated antigens Melan-A and MAGE-3 are overexpressed in a variety of cancer cell types. (NCI Thesaurus)
YOU MAY ALSO LIKE
A vaccine consisting of the melanocyte differentiation antigen Melan A (also called MART-1) encapsulated in noninfectious virus-like particles (VLP) with potential immunostimulating…
A protein found on normal melanocytes (cells that make the pigment melanin) in the skin and in the retina. It is also…
MART-1 (Melanoma Antigen Recognized by T cells, also called Melan-A) is a self antigen expressed on melanocytes and the retina. It…
The essential oil of Melaleuca quinquenervia. Melaleuca quinquenervia oil has antiseptic and antibacterial properties and is used in cosmetic products.
A tree that is a member of the myrtle family. Oil from the tea tree is used in shampoos and skin care…
A drug used alone or with dabrafenib to treat melanoma that cannot be removed by surgery or has spread to other parts…
